Paid Clinical Trials Minneapolis

Discover 647 paid clinical trials in Minneapolis, Minnesota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 647

FT825/ONO-8250 & Monoclonal AntibodiesFT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, with or Without Monoclonal Antibodies in Advanced Solid Tumors

Recruiting

PHASE1

Sponsor:

Fate Therapeutics

Location:

Minneapolis MN, Chicago IL, Saint Louis MO, Detroit MIshow 10 more

Code:

NCT06241456

Conditions

Advanced Solid Tumor

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

FT825

Fludarabine

Cyclophosphamide

Bendamustine

Docetaxel

Investigational CMV Vaccine Study for Volunteers Ages 9–15Investigational CMV Vaccine Study for Volunteers Ages 9–15

PHASE1

PHASE2

Sponsor:

Moderna

Location:

Omaha NE, Norfolk NE, Lincoln NE, Detroit MIshow 43 more

Code:

NCT05575492

Conditions

Cytomegalovirus

Eligibility Criteria

Sex: All

Age: 9 - 15

Healthy Volunteers: Accepted

Interventions

mRNA-1647

Placebo

NutritionStrength and Muscle Related Outcomes for Nutrition and Lung Function in CF

Recruiting

Sponsor:

Jaeb Center for Health Research

Location:

Minneapolis MN, Iowa City IA, Chicago IL, Saint Louis MOshow 18 more

Code:

NCT05639556

Conditions

Cystic Fibrosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BMI and lean mass index from DXA

Anthropometric Measurements

Hand-grip strength

Six-minute walk Test

Sit-to-Stand Test

CFT1946A Study to Characterize the Safety, Tolerability, and Preliminary Efficacy of CFT1946 As Monotherapy and Combination Therapy in Subjects with BRAF V600 Mutant Solid Tumors

Recruiting

PHASE1

PHASE2

Sponsor:

C4 Therapeutics, Inc.

Location:

Minneapolis MN, Madison WI, St. Louis MO, Indianapolis INshow 7 more

Code:

NCT05668585

Conditions

Solid Tumors

Melanoma

NSCLC

CRC

ATC

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

CFT1946

Trametinib

Cetuximab

IVUS Guided TreatmentIMPact on Revascularization Outcomes of IVUS Guided Treatment of Complex Lesions and Economic Impact

Recruiting

Sponsor:

Medstar Health Research Institute

Location:

Minneapolis MN, Duluth MN, Des Moines IA, Chicago ILshow 36 more

Code:

NCT04221815

Conditions

Atherosclerosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Eagle Eye Platinum digital IVUS catheter with optional SyncVision

Resolute Onyx Drug Eluting Stent

Onyx Frontier Drug Eluting Stent

Onyx TruStar Drug Eluting Stent

Onyx TruCor Drug Eluting Stent

EVAR vs. ESARComparison of EVAR and ESAR for Infrarenal Aortic Aneurysms With a Wide Proximal Neck

Recruiting

Sponsor:

Rijnstate Hospital

Location:

Washington AR, Minneapolis MN, Maywood IL, Columbia MOshow 10 more

Code:

NCT05484115

Conditions

Aortic Aneurysm, Abdominal

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

endovascular aneurysm repair (EVAR) using the Endurant II/IIs stent graft system

endosuture aneurysm repair (ESAR) using Heli-FX EndoAnchor system

Tinengotinib vs. Physician's ChoiceStudy of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma

Recruiting

PHASE3

Sponsor:

TransThera Sciences (Nanjing), Inc.

Location:

Minneapolis MN, Milwaukee WI, Chicago IL, Ann Arbor MIshow 13 more

Code:

NCT05948475

Conditions

Cholangiocarcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tinengotinib 8 mg

Tinengotinib 10 mg

Physician's Choice

RMT & Durvalumab, ChemoRMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial

Recruiting

PHASE2

Sponsor:

Masonic Cancer Center, University of Minnesota

Location:

Minneapolis MN

Code:

NCT04105270

Conditions

Adenocarcinoma of Lung

Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Oral Restorative Microbiota Therapy (RMT) Capsules

Durvalumab 1500 mg IV

Cisplatin/pemetrexed or Carboplatin/pemetrexed

Placebo

Ventral IncisionProphylactic Reinforcement of Ventral Abdominal Incisions Trial

Recruiting

Sponsor:

C. R. Bard

Location:

Minneapolis MN, Omaha NE, Peoria IL, Kansas City MOshow 22 more

Code:

NCT03911700

Conditions

Open Midline Laparotomy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Phasix™ Mesh

Observational StudyRacial and Economic Disparities and Unmet Needs in Patients With Severe Aortic Valvular Disease

Recruiting

Sponsor:

Minneapolis Heart Institute Foundation

Location:

Minneapolis MN

Code:

NCT04525937

Conditions

Disparities in Treatment of Aortic Valve Stenosis

Aortic Valve Stenosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Patient Questionnaire

Provider Questionnaire

HighLifeAn Early Feasibility Study of the HighLife 28mm Trans-Septal Transcatheter Mitral Valve Replacement System

Recruiting

Sponsor:

HighLife SAS

Location:

Minneapolis MN, Atlanta GA, Richmond VA, Philadelphia PAshow 6 more

Code:

NCT04029337

Conditions

Mitral Regurgitation

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Transcatheter Mitral Valve Replacement